Your browser doesn't support javascript.
loading
Skin autofluorescence of advanced glycation end products and course of affective disorders in the lifelines cohort study, a prospective investigation.
Hagen, Julia M; Sutterland, Arjen L; Schirmbeck, Frederike; Cohn, Danny M; Lok, Anja; Tan, Hanno L; Zwinderman, Aeilko H; de Haan, Lieuwe.
Afiliação
  • Hagen JM; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, Netherlands.
  • Sutterland AL; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, Netherlands.
  • Schirmbeck F; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, Netherlands; Arkin Mental Health Institute, Amsterdam, Netherlands.
  • Cohn DM; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam, Netherlands.
  • Lok A; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, Netherlands; The Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, Netherlands. Electronic address: a.lok@amsterdamumc.nl.
  • Tan HL; The Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, Netherlands; Amsterdam UMC, University of Amsterdam, Department of Cardiology, Heart Center, Amsterdam, Netherlands; Netherlands Heart Institute, Utrecht, Netherlands.
  • Zwinderman AH; Amsterdam UMC, University of Amsterdam, Department of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam, Netherlands.
  • de Haan L; Amsterdam UMC, University of Amsterdam, Department of Psychiatry, Amsterdam, Netherlands; Arkin Mental Health Institute, Amsterdam, Netherlands; The Amsterdam Public Health research institute, Amsterdam UMC, Amsterdam, Netherlands.
J Affect Disord ; 276: 424-432, 2020 11 01.
Article em En | MEDLINE | ID: mdl-32871673
ABSTRACT

BACKGROUND:

Skin autofluorescence (SAF), indicating concentration of advanced glycation end products in the skin and oxidative stress, is cross-sectionally associated with affective disorders. Prospective studies of oxidative stress markers will help to clarify the pathophysiological role of oxidative stress.

METHODS:

Data of a population-based cohort study were used. Presence of major depressive disorder, dysthymia, generalised anxiety disorder, panic disorder or social phobia was assessed at baseline and at 5-year follow-up with the Mini-International Neuropsychiatric Interview. Associations between SAF at baseline and incidence and persistence/recurrence of affective disorders were assessed with logistic regression.

RESULTS:

Of 43,267 participants with no disorder at baseline, 2885 (6.7%) developed an incident disorder during follow-up. In 1360 of 3648 participants (37.3%) with an affective disorder at baseline, a persisting/recurrent disorder was present at follow-up. A modest association existed between SAF and incident affective disorders (OR=1.07 [95%CI 1.03-1.12], P<.001), specifically major depressive disorder (OR=1.11 [95%CI 1.04-1.19], P=.003); this association lost statistical significance after adjustment for sociodemographic factors. Associations between SAF and persistence/recurrence were not significant.

LIMITATIONS:

Many confounders might also act as intermediate extensive adjustment for confounders caused overfitting and possibly masked effects of SAF on course of affective disorders. Relatively small sample sizes for analyses of SAF and persistence/recurrence of affective disorders resulted in a low power.

CONCLUSIONS:

Increased SAF modestly raises the odds of incident affective disorders, particularly major depressive disorder, providing evidence that oxidative stress plays a role in subsequent occurrence of affective disorders. However, significance of effects faded after adjustment for socioeconomic status.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Finais de Glicação Avançada / Transtorno Depressivo Maior Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Finais de Glicação Avançada / Transtorno Depressivo Maior Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article